Immune-based Therapy Pilot Study for the Treatment of Primary HIV Infection (PHI-IMD).
Condition: HIVInterventions: Drug: HAART; Drug: HAART + ImmunotherapySponsor: Juan A. ArnaizCompleted - verified November 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials